Extending human healthspan.

Epigenetically reprogramming cells to younger states

NewLimit is inventing medicines to restore youthful function in old cells by reprogramming the epigenome. We leverage enabling technologies spanning single cell genomics, machine learning, and high-throughput functional assays to reveal epigenetic features of aging and discover rejuvenating interventions.

Diseases, then longevity.

Our Approach
Our 20-year ambition is to significantly extend human healthspan. We are developing epigenetic reprogramming medicines for diseases of aging as stepping stones to that goal.

Our first programs are restoring youthful function in the aging immune system & liver.

Read the latest news from NewLimit

See All News